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ABSTRACT 
The number of persons taking part in organized 
sports in our islands is increasing every year. Many 
of these athletes and the events that they participate 
in are subject to doping control tests by the National 
Anti-Doping Organisation (NADO) or the national 
federation or association of their particular sport. 
A small number of these tests record a prohibited 
substance present in the athlete’s sample, which may 
have serious consequences on the sporting career 
of the athlete. Many athletes consult their general 
practitioner (GP) or team doctor regularly for advice 
when they develop a medical condition. This article 
is intended to provide the GP with background 
information regarding drugs that may be used 
safely and without consequences for the athlete, the 
procedure to follow when the athlete needs to be 
treated with drugs which are prohibited to athletes, 
and the pitfalls of accidental doping.
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INTRODUCTION
The sanctioning of star tennis player Maria Sharapova 
in 2016, following alleged medical use of the drug 
meldonium, resulted in a spate of media activity which 
brought to the attention of the world the possibility of 
athletes being sanctioned when using drugs prescribed 
legitimately. The drug was declared a prohibited drug 
on 1st January 2016 and resulted in a total of 283 
positive tests worldwide during that year. It is prudent 
to bring the issue of safe prescribing to athletes to the 
attention of the family doctor / general practitioner 
(GP), and provide the necessary tools to make an 
informed decision when treating athletes. Contrary to 
normal patients, athletes are not allowed to use certain 
medications as this may result in a positive doping 
control test, which could lead to a sanction.
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REViEw ARTiCLE
The World Anti-Doping Agency (WADA) was 
established in 1999 as an international, independent 
agency composed and funded equally by the sport 
movement and governments of the world. Its key 
activities include scientific research, education, 
development of anti-doping capacities, and monitoring 
of the World Anti-Doping Code (WADC/Code) – the 
document harmonizing anti-doping policies in all sports 
and all countries. The first Code was drawn up in 2004 
and revised in 2015.
Malta ratified the Anti-Doping Convention of the 
Council of Europe and the UNESCO Convention 
against Doping in Sport in 2011. The first Anti-Doping 
Regulations were passed in 2011 (LN 281 of 2011) and 
the Maltese National Anti-Doping Organisation (NADO) 
started operation in February 2012 in line with the 
WADC. Since then the Anti-Doping regulations were 
changed in 2015 (LN 17 of 2015) to be in line with the 
new WADC, which, in a nutshell, lays down the rules on 
what constitutes an Anti-Doping Rule Violation (ADRV) 
and how the NADO should conduct its operation (Anti-
Doping Regulations of Malta, 2015). This involves testing, 
results management and sanctioning. Since its inception, 
Maltese NADO has carried out 441 doping control tests 
and sanctioned 18 athletes. 
There are 10 ADRVs in our law and the WADC. These 
are summarised in Table 1. The most common ADRV 
by far is finding the presence of a prohibited substance 
or its metabolites in an athlete’s sample. This is what 
constitutes a positive doping control test.
THE PROHIBITED LIST
The WADA Prohibited List (List) is the comprehensive 
document serving as the international standard in 
identifying substances and methods prohibited in all 
sports (World Anti-Doping Agency, 2017). The List is 
revised every year after months of review by experts and 
stakeholders and comes into force on 1st January of every 
year. The Maltese Anti-Doping Regulations refer to this 
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document and a copy is published in the Government 
Gazette in January of every year and it is also available 
online. It is very important that athletes and their medical 
providers are aware that changes may occur from year 
to year according to new evidence which would have 
emerged regarding performance enhancing drugs.
A substance or method is considered by WADA for 
inclusion in the prohibited list if it meets two of the 
following three criteria:
•	 Medical or scientific evidence, pharmacological 
effect, or experience that it has the potential to 
enhance or enhances sport performance.
•	 Medical or scientific evidence, pharmacological 
effect, or experience that the substance represents 
an actual or potential health risk to the athlete.
•	 Use of the substance is considered to violate the 
spirit of sport.
All athletes participating in organized sports are subject 
to doping control testing at all times. The definition of 
athlete in the Maltese legislation is as follows: “athlete” 
means any person who competes in sport at the international level 
as defined by each international federation or at the national level 
as defined by each national anti-doping organisation.” This means 
that any person registered with a local sporting association or 
federation, or who participates in a competition organized by 
the same, is bound to abide by the anti-doping regulations. 
These athletes may be tested not only during a competition 
but also at other times (out of competition).
The Maltese Anti-Doping Regulations and the WADC 
stipulate athlete ‘strict liability’. This principle is applied 
in situations where urine or blood samples collected 
from an athlete have produced adverse analytical results, 
and means that the athlete is held responsible for the 
substances found in his or her bodily specimen. An 
anti-doping rule violation occurs whenever a prohibited 
substance (or its metabolites or markers) is found in the 
specimen, whether or not the athlete intentionally or 
unintentionally used a prohibited substance (even if it 
was legitimately prescribed by a doctor) or was negligent 
or otherwise at fault. This means that the athlete is 
solely responsible for any prohibited substance found 
in his sample and needs to be very vigilant about which 
medications or substances he or she might be consuming 
at all times, not just around the time of competition.
The substances and methods included in the List are 
divided into 4 sections as follows:
•	 Substances prohibited at all times (Table 2). 
These drugs cannot be used by athletes in and 
out of competition. This section includes anabolic 
steroids, beta 2 agonists, diuretics and growth 
hormone among others.
•	 Substances prohibited in-competition only (Table 
3). This section includes stimulants, narcotics, 
glucocorticoids and cannabinoids. The athlete 
must pay attention to stop any medication 
containing any of these drugs early enough for the 
all of the drug to be metabolized and cleared by the 
Table 1: Antidoping rule violations
1 The presence of a prohibited substance or its metabolites or markers in the athlete’s sample.
2 The use or attempted use of a prohibited substance or prohibited method.
3 Evading sample collection or refusing or failing to submit to sample collection.
4 Any combination of three missed tests or filing failures in one calendar year.
5 Tampering or attempted tampering with the doping control process.
6 Possession by an athlete support personnel of any prohibited substance or method in and out of competition.
7 Trafficking or attempted trafficking of a prohibited substance or method.
8 Administration or attempted administration to an athlete of any prohibited substance or method.
9 Assisting, encouraging, aiding, abetting, conspiring, covering up involving an ADRV.
10 Prohibited association.
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Table 2: Substances prohibited at all times
Class Examples of substances
S0. Non approved 
substances
Any pharmacological 
substance not addressed by 
the other subsections and 
not approved for human 
therapeutic use
Drugs under clinical or 
pre-clinical development 
or discontinued, designer 
drugs, drugs approved only 
for veterinary use
GW501516
S1. Anabolic agents 1. Anabolic androgenic 
steroids (AAS)
Exogenous AAS Bodenone,	nandrolone,	
stanazolol
Endogenous AAS, when 
administered exogenously
Testosterone, DHEA, 
androsterone, epitestoterone
2. Other anabolic agents Clenbuterol, selective 
androgen receptor 
modulators (SARM’s), 
tibolone, zilpaterol
S2. Peptide hormones, 
growth factors, related 
substances and mimetics
1. Erythropoetin-receptor 
agonists
1.1 Erythropoesis 
stimulating agents (ESA’s) 
EPO, dEPO, CERA
1.2 Non erythropoetic EPO-
receptor agonists
ARA-290, asialo EPO, 
carbamylated EPO
2. Hypoxia inducible factor 
(HIF)
HIF stabilisers HIF stabilisers e.g. cobalt, 
HIF activators e.g. argon, 
xenon
3. Chorionic gonadotrophin 
(CG) & luteinsing hormone 
(LH) & their releasing 
factors in MALES
•	 Buserelin,
•	 gonadorelin,
•	 leuprorelin
4. Corticotrophins and their 
releasing factors
•	 Corticorelin
5. Growth hormone (GH) 
and its releasing factors
Growth hormone releasing 
hormone (GHRH) and its 
analogues, secretagogues 
(GHS) and releasing 
peptides (GHRP’s)
•	 CJC-1295, sermorelin, 
ghrelin, GHRP-6, hexarelin
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Class Examples of substances
Additional prohibited 
growth factors
•	 IGF-1, FGF. HGF, VGEF, 
PDGF
S3.	Beta2	agonists All beta2 agonists including 
optical isomers EXCEPT 
INHALED salbutamol, 
salmeterol, formoterol in 
therapeutic doses
Terbutaline, albuterol
S.4 Hormone and 
metabolic modulators
1. Aromatase inhibitors Aminoglutethimide, 
anastrolzole, formestane
2. Selective estrogen 
receptors modulators 
(SERM’s)
Tamoxifen, raloxifen, 
toremifen
3. Other anti-estrogenic 
substances
Clomiphene, cyclofenil, 
fluvestrant
4. Agents modifying 
myostatin function
Myostatin inhibitors
5. Metabolic modulators Meldonium, insulin 
and insulin-mimetics, 
trimetazine
S.5 Diuretics and 
masking agents
All diuretics & masking 
agents 
EXCEPT drosperinone, 
pamabrom, ophthalmic 
use of carbonic anhydrase 
inhibitors, local use of 
fenylpressin in dental 
anasethesia
Probenicid, acetazolamide, 
bumetanide, furosemide, 
indapamide, thiazides, 
spironolactone
body in time for competition. Different substances 
have got different rates for elimination and this also 
varies from person to person.
•	 Substances which are prohibited in particular 
sports only (Table 4). This section includes alcohol, 
and beta blockers, which are prohibited in certain 
sports.
•	 Prohibited methods (Table 5). Examples of this 
category include blood transfusions, intravenous 
infusions and genetic manipulation.
The List provides a long list of examples of drugs in 
each category. However it needs to be emphasized that all 
drugs belonging to the particular categories are prohibited 
even if they are not mentioned in the List.
THERAPEUTIC USE EXEMPTIONS (TUE'S)
When an athlete has a health condition, which demands 
treatment or medication, it is extremely important for 
the athlete and/or the doctor to check the status of the 
substance or method to be used with the Prohibited 
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List. If the substance or treatment method is prohibited, 
the athlete must apply for and obtain a Therapeutic 
use Exemption (TUE) from the NADO (available from 
http://nadomalta.org/tue-form), and treatment 
must not start until this confirmation is received. Only 
in acute medical emergencies is an athlete allowed to 
start treatment before the TUE is approved. There is no 
guarantee that, in every case, an approval will be granted 
retrospectively. Although the doctor completes much of 
the TUE application form for the athlete, it remains the 
athlete’s responsibility to ensure that they have a valid 
TUE when they are taking, or have taken, a prohibited 
substance, or used a prohibited method.
The evaluation of TUEs by the NADO is governed 
by a mandatory International Standard for Therapeutic 
Use Exemptions (ISTUE). This standard first came into 
effect in January 2005 with several revisions since then, 
the latest one came into effect on 1 January 2016. 
According to the ISTUE, an athlete may be granted 
a TUE if, (and only if), he/she can show, by a balance of 
probability, that each of the following conditions is met: 
1. The prohibited substance or prohibited method 
in question is needed to treat an acute or chronic 
medical condition, such that the athlete would 
experience a significant impairment to health if the 
prohibited substance or prohibited method were to 
be withheld. 
2. The therapeutic use of the prohibited substance or 
prohibited method is highly unlikely to produce 
any additional enhancement of performance 
beyond what might be anticipated by a return 
to the athlete’s normal state of health following 
the treatment of the acute or chronic medical 
condition. 
3. There is no reasonable therapeutic alternative to 
the use of the prohibited substance or prohibited 
method. 
4. The necessity for the use of the prohibited 
substance or prohibited method is not a 
consequence, wholly or in part, of the prior use 
(without a TUE) of a substance or method which 
was prohibited at the time of such use.
Table 3: Substances prohibited in competition: all substances prohibited out of competition and the following
Class Examples of substances
S.6 Stimulants a. Non-specified Amphetamine, bromantan, 
cocaine, fenfluramine, 
mesocarb
b. Specified Note: cathine, ephedrine, 
pseudoephedrine subject to 
urinary levels.
Cathine, ephedrine, 
adrenalin, seleginine, 
pseudoephedrine, 
methylhexanamine, 
dimethylbutylamine
S.7 Narcotics Morphine, pethidine, 
fentanyl, mathadone
S.8 Cannabinoiods a. Natural Marijuana, hashish, 
cannabis, THC
b. Cannabimimetics “Spice”, JWH-018, JWH-
073, HU-210
S.8 Glucocorticoids All prohibited when 
administered by oral, intra-
muscular, intra-venous, 
rectal route
Allowed when administered 
by inhalation, nasal, dermal, 
ophthalmological applications
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Table 4: Substances prohibited in particular sports
Class Comments Sports Examples of substances
P.1 Alcohol (ethanol) Blood	concentration	
threshold of 0.10 g/L
Air sports, archery, 
automobile, powerboating
P.2	Beta-blockers Prohibited in competition Archery, automobile, 
billiards, darts, golf, 
shooting, skiing, 
snowboarding, ski jumping, 
underwater sports
Atenolol, carvedilol, 
labetalol, propranolol, 
sotalol, timolol etc.
Prohibited in-competition 
and out-of-competition
Archery, shooting
Table 5: Prohibited methods
Class Comments
M1. Manipulation of blood 
and blood components
1. Administration or reintroduction of any quantity of autologous, allogenic (homologous) or 
heterologous blood or red blood cell products of any origin into the circulatory system.
2. Artificially enhancing the uptake, transport or delivery of oxygen. Including, but not limited to: 
perfluorochemicals, efaproxiral (RSR13) and modified haemoglobin products e.g. haemoglobin-based 
blood substitutes and microencapsulated haemoglobin products, excluding supplemental oxygen.
3. Any form of intravascular manipulation of the blood or blood components by physical or 
chemical means.
M2. Chemical and 
physical manipulations
1. Tampering, or attempting to tamper, to alter the integrity and validity of samples collected during 
doping control, including but not limited to: urine substitution and/or adulteration, e.g. proteases.
2. Intravenous infusions and/or injections of more than 50 mL per 6 hour period except for 
those legitimately received in the course of hospital admissions, surgical procedures or clinical 
investigations.
M3. Gene doping 1. The transfer of polymers of nucleic acids or nucleic acids analogies.
2. The use of normal or genetically modified cells.
One of the basic principles for treating athletes 
is to prescribe medication or treatments that are not 
prohibited. For example a hypertensive athlete who 
needs treatment can be prescribed several classes of 
allowed drugs, but not diuretics and beta-blockers (the 
latter in certain sports only, Table 4). The only situation 
where these drugs may be considered for a TUE is when 
the athlete can provide sound medical evidence that all 
allowed drugs were not effective in controlling his blood 
pressure and he responds only to the prohibited ones. 
The TUE application needs to be accompanied by medical 
evidence to prove this.
There is a belief among the local sports community 
that as long as a TUE application form is filled in and 
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submitted, it will be accepted automatically and TUE 
granted. This is not the case. The TUE Committee 
needs to be convinced that the condition that 
requires the prohibited drug exists and there is no 
other alternative treatment. Comprehensive medical 
evidence needs to accompany the application. This 
includes a detailed medical report, any laboratory 
and test results and imaging studies. The TUE panel 
takes all the evidence into consideration and reaches 
a decision whether to grant or refuse the TUE. This 
decision has to be in line with ISTUE standards. There 
have been instances where doctors have insisted on 
their right to decide how and when to treat patients. 
This can be understandable for the non-athletic 
population. However, with regards to athletes that 
have to abide by the WADA code, prescription must 
be guided by the relevant anti-doping regulations.
RETROACTIVE TUE's
There are infrequent situations for which TUE’s may 
be granted retroactively. These cases are evaluated in 
the same way as standard TUE applications i.e. the 
TUE Committee evaluates the application and issues 
its decision. The ISTUE stipulates which situations may 
result in the granting of a retroactive TUE, as follows:
1. Emergency treatment or treatment of an acute 
medical condition was necessary (a medical 
emergency or acute medical situation is one 
which justifies immediate administration of 
a prohibited substance or method and failure 
to treat immediately could significantly put the 
athlete’s health at risk). It is always preferable to 
address a TUE application prospectively rather 
than retrospectively; or
2. Due to other exceptional circumstances, there was 
insufficient time or opportunity for the athlete to 
submit, or the TUEC to consider, an application for 
the TUE prior to sample collection; or
3. Applicable rules for the particular sport required 
the athlete or permitted the athlete to apply for a 
retroactive TUE.
4. It is agreed, by WADA and by the NADO to whom 
the application for a retroactive TUE is or would 
be made, that fairness requires the grant of a 
retroactive TUE.
Once a TUE is granted, this would be for a specific 
method or substance, with a defined dosage and route 
of administration. It would also be for a specific period 
of time and would, therefore, have an expiry date. The 
TUE approval certificate should, ideally, be presented 
to doping control officials at the time of any eventual 
doping controls. When the doping control authority 
receives a report of an adverse analytical finding from the 
laboratory, an initial evaluation will take place to verify 
that the TUE is still in effect and that the results of the 
analysis are consistent with the TUE granted (nature of 
substance, route of administration, dose, time frame 
of administration, etc.). If the review is satisfactory, 
the result of the test will be recorded as negative. It is 
important to note that rejected TUE's can be appealed to 
WADA under the rules of International Federations and 
NADOs. However, one may always reapply to the NADO 
to have a new TUE application considered, especially if 
new compelling medical information is presented.
PITFALLS FOR THE ATHLETE AND THE GP
As explained above, the athlete is always responsible for 
what goes into his body. Therefore he needs to discuss 
both the need and the choice of medication with the 
doctor, pointing out that he may be subject to doping 
control. There are online applications that may be 
accessed to check whether medications are prohibited or 
not. A useful one is a website maintained by the United 
Kingdom, Canadian, Japanese, Swiss, Australian and 
Unites States authorities called Global DRO which can 
be accessed at http://www.globaldro.com/UK/search.
The commonest situations where accidental doping 
may occur are when using:
1. ‘Cold & flu’ and cough preparations. Many times 
these contain drugs from the stimulant class, 
which would help to relieve the nasal congestion 
e.g.	ephedrine,	pseudo-ephedrine.	Both	these	
drugs are prohibited in-competition up to a certain 
urine concentration. The athlete and doctor 
must make sure that they are not consumed 
within a week of competition to allow time for 
the drug and its metabolites to be cleared from 
the body. A better solution would be to avoid 
these preparations altogether and use alternative 
medications like intranasal decongestants, e.g. 
xylometazoline, which are allowed.
2. Supplements. The majority of athletes make use of 
different kinds of dietary supplements to enhance 
their nutrition and optimise performance. The 
most widely used are protein, creatine, amino acids 
and various combinations of vitamins. Several 
studies have reported that prohibited substances 
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were found in a number of supplements on the 
market	varying	from	3-19%	of	the	total	number	of	
supplements tested (Geyer et al., 2014; Judkins, 
Hall and Hoffman, 2007; Judkins, 2008; Kamber 
et al., 2001). These drugs would not be declared 
on the list of ingredients and athletes would 
think that the supplements are safe to consume. 
Classes of drugs most commonly found in these 
studies were anabolic steroids and stimulants. 
Contamination of these supplements may occur 
either as a deliberate, undeclared inclusion by 
the manufacturer to increase the effect of the 
supplement, or cross contamination during 
manufacture from poorly maintained machinery. In 
2013, Jamaican athletes Asafa Powell and Sharon 
Simpson tested positive after making use of a 
supplement called Epiphany D3 which was spiked 
with an undeclared stimulant oxilofrine. (Drayton, 
2014), and were eventually sanctioned. 
3. Herbal medication or supplements. Such products 
are usually labeled as “natural”, and athletes 
mistakenly believe that they are safe. Plants may 
contain metabolically active substances which are 
prohibited. For example, the Chinese herb ma 
huang is the equivalent of ephedra and contains 
ephedrine. ‘Geranium oil’ product labeling is 
often associated with the banned stimulant 
methylhexaneamine (DMAA). In actual fact 
geranium oils do not contain methylhexaneamine 
but these herbal supplements are spiked with the 
synthetic drug. (Lisi et al, 2011).
WADA and the International Olympic Committee 
advise athletes not to make use of dietary supplements 
as that is the only way to make sure that no prohibited 
substances are consumed inadvertently. Otherwise athletes 
need to scrutinize in detail the contents of supplements 
and only consume those which have been batch tested 
by the manufacturer. There are several websites which list 
supplements that are batch tested, and therefore safer for 
consumption by athletes than those which are not. The 
following are the most useful lists:
1. http://www.informed-sport.com/certified-
product-brands 
2. http://www.koelnerliste.com/en/product-
database.html 
3. http://www.nsf.org
4. http://info.nsf.org/Certified/Dietary/
CONCLUSION
Athletes need to be vigilant about what they are 
consuming. Their health care providers must be aware 
that certain drugs may not be used by athletes as they 
may result in serious consequences for the athletes and 
their sporting careers. TUE requests must be filled in 
correctly and comprehensively and always backed by 
sound medical evidence. There are several online tools 
to help both athlete and doctor to arrive at an informed 
decision. It is also important to keep in mind that the 
Prohibited List is subject to change every year from the 
1st of January.
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